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Abstract
Enzymes that catalyze carbon–silicon bond formation are unknown in nature, despite the natural 
abundance of both elements. Such enzymes would expand the catalytic repertoire of biology, 
enabling living systems to access chemical space previously only open to synthetic chemistry. We 
have discovered that heme proteins catalyze the formation of organosilicon compounds under 
physiological conditions via carbene insertion into silicon–hydrogen bonds. The reaction proceeds 
both in vitro and in vivo, accommodating a broad range of substrates with high chemo- and 
enantioselectivity. Using directed evolution, we enhanced the catalytic function of cytochrome c 
from Rhodothermus marinus to achieve more than 15-fold higher turnover than state-of-the-art 
synthetic catalysts. This carbon–silicon bond-forming biocatalyst offers an environmentally 
friendly and highly efficient route to producing enantiopure organosilicon molecules.
Silicon constitutes almost 30% of the mass of the Earth’s crust, yet no life form is known to 
have the ability to forge carbon–silicon bonds (1). Despite the absence of organosilicon 
compounds in the biological world, synthetic chemistry has enabled us to appreciate the 
unique and desirable properties that have led to their broad applications in chemistry and 
material science (2, 3). As a biocompatible carbon isostere, silicon can also be used to 
optimize and repurpose the pharmaceutical properties of bioactive molecules (4, 5).
The natural supply of silicon may be abundant, but sustainable methods for synthesizing 
organosilicon compounds are not (6–8). Carbon–silicon bond forming methods that 
introduce silicon motifs to organic molecules enantioselectively rely on multi-step synthetic 
campaigns to prepare and optimize chiral reagents or catalysts; precious metals are also 
sometimes needed to achieve the desired activity (9–15). Synthetic methodologies such as 
carbene insertion into silanes can be rendered enantioselective using chiral transition metal 
complexes based on rhodium (11, 12), iridium (13) and copper (14, 15). These catalysts can 
provide optically pure products, but not without limitations: they require halogenated 
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solvents and sometimes low temperatures to function optimally and have limited turnovers 
(<100) (16).
Because of their ability to accelerate chemical transformations with exquisite specificity and 
selectivity, enzymes are increasingly sought after complements to or even replacements for 
chemical synthesis methods (17, 18). Biocatalysts that are fully genetically encoded and 
assembled inside of cells are readily tunable using molecular biology techniques. They can 
be produced at low cost from renewable resources in microbial systems and perform 
catalysis under mild conditions. Although nature does not use enzymes to form carbon–
silicon bonds, the protein machineries of living systems are often “promiscuous”, that is, 
capable of catalyzing reactions distinct from their biological functions. Evolution, natural or 
in the laboratory, can use these promiscuous functions to generate catalytic novelty (19–21). 
For example, heme proteins can catalyze a variety of non-natural carbene transfer reactions 
in aqueous media, including N–H and S–H insertions, which can be greatly enhanced and 
made exquisitely selective by directed evolution (22–24).
We hypothesized that heme proteins might also catalyze carbene insertion into silicon–
hydrogen bonds. Because iron is not known to catalyze this transformation (25), we first 
examined whether free heme could function as a catalyst in aqueous media. Initial 
experiments showed that the reaction between phenyldimethylsilane and ethyl 2-
diazopropanoate (Me-EDA) in neutral buffer (M9-N minimal medium, pH 7.4) at room 
temperature gave racemic organosilicon product 3 at very low levels, a total turnover number 
(TTN) of 4 (Fig. 1A). No product formation was observed in the absence of heme, and the 
organosilicon product was stable under the reaction conditions.
We next investigated whether heme proteins could catalyze the same carbon–silicon bond-
forming reaction. Screening a panel of cytochrome P450 and myoglobin variants, we 
observed product formation with more turnovers compared to the hemin and hemin with 
bovine serum albumin (BSA) controls, but with negligible enantioinduction (Table S4). 
Interestingly, cytochrome c from Rhodothermus marinus (Rma cyt c), a gram-negative, 
thermohalophilic bacterium from submarine hot springs in Iceland (26), catalyzed the 
reaction with 97% ee, indicating the reaction took place in an environment where the protein 
exerted excellent stereocontrol. Bacterial cytochromes c are well-studied, functionally 
conserved electron-transfer proteins that are not known to have any catalytic function in 
living systems (27). Other bacterial and eukaryotic cytochrome c proteins also catalyzed the 
reaction, but with lower selectivities. We thus chose Rma cyt c as the platform for evolving a 
carbon–silicon bond-forming enzyme.
The crystal structure of wild-type Rma cyt c (PDB ID: 3CP5; 26) reveals that the heme 
prosthetic group resides in a hydrophobic pocket, with the iron axially coordinated to a 
proximal His (H49) and a distal Met (M100), the latter of which is located on a loop (Figs. 
1B and 1C). The distal Met, common in cytochrome c proteins, is coordinately labile (28, 
29). We hypothesized that M100 must be displaced upon iron-carbenoid formation, and that 
mutation of this amino acid could facilitate formation of this adventitious “active site” and 
yield an improved carbon–silicon bond-forming biocatalyst. Therefore, a variant library 
made by site-saturation mutagenesis of M100 was cloned and recombinantly expressed in E. 
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coli. After protein expression, the bacterial cells were heat-treated (75 °C for 10 min) before 
screening in the presence of phenyldimethylsilane (10 mM), Me-EDA (10 mM) and sodium 
dithionite (Na2S2O4 10 mM) as a reducing agent, at room temperature under anaerobic 
conditions. The M100D mutation stood out as highly activating: this first-generation mutant 
provided chiral organosilicon 3 as a single enantiomer in 550 TTN, a 12-fold improvement 
over the wild-type protein (Fig. 1D).
Amino acid residues V75 and M103 reside close (within 7Å) to the iron heme center in 
wild-type Rma cyt c. Sequential site-saturation mutagenesis at these positions in the M100D 
mutant led to the discovery of triple mutant V75T M100D M103E, which catalyzed carbon–
silicon bond formation in >1500 turnovers and >99% ee. This level of activity is more than 
15 times the total turnovers reported for the best synthetic catalysts for this class of reaction 
(16). As stand-alone mutations, both V75T and M103E are activating for wild-type Rma cyt 
c and the beneficial effects increase with each combination (Table S5). Comparison of the 
initial reaction rates established that each round of evolution enhanced the rate: relative to 
the wild-type protein, the evolved triple mutant catalyzes the reaction >7-fold faster, with 
turnover frequency (TOF) of 46 min−1 (Fig. 1E).
Assaying the new enzyme against a panel of silicon and diazo reagents, we found that the 
mutations were broadly activating for enantioselective carbon–silicon bond formation. The 
reaction substrate scope was surveyed using heat-treated lysates of E. coli expressing Rma 
cyt c V75T M100D M103E under saturating conditions for both silane and diazo ester to 
determine TTN. Whereas many natural enzymes excel at catalyzing reactions on only their 
native substrates and little else (especially primary metabolic enzymes), the triple mutant 
catalyzed the formation of twenty silicon-containing products, most of which were obtained 
cleanly as single enantiomers, showcasing the broad substrate scope of this reaction using 
just a single variant of the enzyme (Fig. 2). The reaction accepts both electron-rich and 
electron-deficient silicon reagents, accommodating a variety of functional groups including 
ethers, aryl halides, alkyl halides, esters and amides (5–10). Silicon reagents based on 
naphthalenes or heteroarenes (11–13) as well as vinyldialkyl- and trialkylsilanes could also 
serve as silicon donors (14, 15, 18). In addition, diazo compounds other than Me-EDA could 
be used for carbon–silicon bond formation (16, 17) (16).
The evolved Rma cyt c exhibits high specificity for carbon–silicon bond formation. Even in 
the presence of functional groups that could compete in carbene-transfer reactions, 
enzymatic carbon–silicon bond formation proceeded with excellent chemoselectivity. For 
example, styrenyl olefins, electron-rich double bonds, and terminal alkynes that are prime 
reaction handles for synthetic derivatization are preserved under the reaction conditions, 
with no competing cyclopropanation or cyclopropenation activity observed. As a result, 
organosilicon products 12–13 and 18–20 were afforded with 210 to 5010 turnovers and 
excellent stereoselectivities (98 to >99% ee). Preferential carbon–silicon bond formation 
could also be achieved with substrates bearing free alcohols and primary amines, yielding 
silicon-containing phenol 21 (910 TTN, >99% ee) and aniline 22 (8210 TTN, >99% ee). 
This capability removes the need for functional group protection and/or manipulation, 
offering a streamlined alternative to transition metal catalysis for incorporating silicon into 
small molecules. Indeed, when the same reactants were subjected to rhodium catalysis (1 
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mol% Rh2(OAc)4), O–H and N–H insertions were the predominant reaction pathways, and 
copper catalysis (10 mol% Cu(OTf)2) gave complex mixtures of products (Table S7). 
Tolerance of these highly versatile functionalities in enzymatic carbon–silicon bond-forming 
reactions provides opportunities for their downstream processing through metabolic 
engineering, bioorthogonal chemistry, and other synthetic endeavours.
We next asked whether all Rma cyt c variants would catalyze carbon–silicon bond formation 
selectively over insertion of the carbene into an N–H bond in the same substrate. We re-
visited the evolutionary lineage and tested all four generations of Rma cyt c (wild-type, 
M100D, V75T M100D and V75T M100D M103E) with Me-EDA and 4-
(dimethylsilyl)aniline (23), a reagent that could serve as both nitrogen and silicon donor, to 
probe the proteins’ bond-forming preferences. The wild-type cytochrome c in fact exhibited 
a slight preference for forming amination product 24 over organosilicon product 22. Even 
though silane 23 was not used for screening, and the Rma cyt c therefore never underwent 
direct selection for chemoselectivity, each round of evolution effected a distinct shift from 
amination to carbon–silicon bond forming activity (Fig. 3A). This evolutionary path that 
focused solely on increasing desired product formation culminated in a catalyst that 
channeled the majority of the reactants (97%) through carbon–silicon bond formation (>30-
fold improved with respect to the wild-type), presumably by improving the orientation and 
binding of the silicon donor.
Some fungi, bacteria and algae have demonstrated promiscuous capacities to derivatize 
organosilicon molecules when these substances were made available to them (1). The 
possibility ultimately to establish silicon-based biosynthetic pathways led us to investigate 
whether the evolved Rma cyt c could produce organosilicon products in vivo. E. coli whole 
cells (OD600 = 15) expressing Rma cyt c V75T M100D M103E in glucose-supplemented 
M9-N buffer were given silane 23 (0.1 mmol) and Me-EDA (0.12 mmol) as neat reagents. 
The enzyme in this whole-cell system catalyzed carbon–silicon bond formation with 3410 
turnovers, yielding organosilicon product 22 in 70% isolated yield (>95% yield based on 
recovered silane 23) and 98% ee (Fig. 3B). These in vitro and in vivo examples of carbon–
silicon bond formation using an enzyme and earth-abundant iron affirm the notion that 
nature’s protein repertoire is highly evolvable and poised for adaptation: with only a few 
mutations, existing proteins can be repurposed to efficiently forge chemical bonds not found 
in biology and grant access to areas of chemical space which living systems have not 
explored.
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Fig. 1. Heme protein-catalyzed carbon-silicon bond formation
(A) Carbon–silicon bond formation catalyzed by heme and purified heme proteins. (B) 
Surface representation of the heme-binding pocket of wild-type Rma cyt c (PDB ID: 3CP5). 
(C) “Active site” structure of wild-type Rma cyt c showing a covalently bound heme 
cofactor ligated by axial ligands H49 and M100. Amino acid residues M100, V75 and M103 
residing close to the heme iron were subjected to site-saturation mutagenesis. (D) Directed 
evolution of Rma cyt c for carbon–silicon bond formation (reaction shown in (A)). 
Experiments were performed using lysates of E. coli expressing Rma cyt c variant (OD600 = 
Kan et al. Page 9
Science. Author manuscript; available in PMC 2017 November 25.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
15; heat-treated at 75 °C for 10 min), 10 mM silane, 10 mM diazo ester, 10 mM Na2S2O4, 5 
vol% MeCN, M9-N buffer (pH 7.4) at room temperature under anaerobic conditions for 1.5 
h. Reactions performed in triplicate. (E) Carbon–silicon bond forming rates over four 
generations of Rma cyt c.
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Fig. 2. Scope of Rma cyt c V75T M100D M103E-catalyzed carbon–silicon bond formation
Standard reaction conditions: lysate of E. coli expressing Rma cyt c V75T M100D M103E 
(OD600 = 1.5; heat-treated at 75 °C for 10 min), 20 mM silane, 10 mM diazo ester, 10 mM 
Na2S2O4, 5 vol% MeCN, M9-N buffer (pH 7.4) at room temperature under anaerobic 
conditions. Reactions performed in triplicate. [a] OD600 = 5 lysate. [b] OD600 = 0.5 lysate. 
[c] OD600 = 15 lysate. [d] 10 mM silane. [e] OD600 = 0.15 lysate.
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Fig. 3. Chemoselectivity and in vivo activity of evolved Rma cyt c
(A) Chemoselectivity for carbene Si–H insertion over N–H insertion increased dramatically 
during directed evolution of Rma cyt c. Standard reaction conditions as described in Fig. 2. 
Reactions performed in duplicate using heat-treated lysates of E. coli expressing Rma cyt c 
with protein concentration normalized across variants. Product distribution was quantified 
after 2 h reaction time (before complete conversion, no double insertion product was 
observed under these conditions). (B) In vivo synthesis of organosilicon compound 22.
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